Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases.

Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med (2009) 2.81

Dietary sodium and cardiovascular and renal disease risk factors: dark horse or phantom entry? Nephrol Dial Transplant (2008) 2.25

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev (2009) 2.17

Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A (2007) 1.98

KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet (2012) 1.93

The WNKs: atypical protein kinases with pleiotropic actions. Physiol Rev (2011) 1.88

Thrombin. Mol Aspects Med (2008) 1.80

Under pressure: the search for the essential mechanisms of hypertension. Nat Med (2011) 1.72

A sympathetic view of the sympathetic nervous system and human blood pressure regulation. Exp Physiol (2008) 1.48

Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats. Am J Hypertens (2009) 1.45

How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension. Am J Physiol Heart Circ Physiol (2011) 1.43

How does potassium supplementation lower blood pressure? Am J Physiol Renal Physiol (2012) 1.42

Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nat Clin Pract Nephrol (2008) 1.35

The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension. Hypertension (2008) 1.32

Contemporary nutritional transition: determinants of diet and its impact on body composition. Proc Nutr Soc (2010) 1.28

Upregulation of Na+ and Ca2+ transporters in arterial smooth muscle from ouabain-induced hypertensive rats. Am J Physiol Heart Circ Physiol (2009) 1.24

Genetics of salt-sensitive hypertension. Curr Hypertens Rep (2011) 1.21

Role of epithelial sodium channels and their regulators in hypertension. J Biol Chem (2010) 1.20

Salt overload damages the glycocalyx sodium barrier of vascular endothelium. Pflugers Arch (2011) 1.19

Paleolithic nutrition for metabolic syndrome: systematic review and meta-analysis. Am J Clin Nutr (2015) 1.12

Dietary sodium and health: more than just blood pressure. J Am Coll Cardiol (2015) 1.11

Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice. Am J Physiol Heart Circ Physiol (2008) 1.11

Exposure to maternal diabetes induces salt-sensitive hypertension and impairs renal function in adult rat offspring. Diabetes (2008) 1.10

Cellular mediators of renal vascular dysfunction in hypertension. Am J Physiol Regul Integr Comp Physiol (2009) 1.08

Allelic-based gene-gene interaction associated with quantitative traits. Genet Epidemiol (2009) 1.07

Bradykinin acutely inhibits activity of the epithelial Na+ channel in mammalian aldosterone-sensitive distal nephron. Am J Physiol Renal Physiol (2011) 1.06

Dietary sodium loading impairs microvascular function independent of blood pressure in humans: role of oxidative stress. J Physiol (2012) 1.05

Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice. Am J Physiol Heart Circ Physiol (2010) 1.05

Sodium-selective salt sensitivity: its occurrence in blacks. Hypertension (2007) 1.03

What initiates the pressor effect of salt in salt-sensitive humans? Observations in normotensive blacks. Hypertension (2007) 1.03

Crystal structure of KLHL3 in complex with Cullin3. PLoS One (2013) 1.02

Reactive oxygen species and dopamine receptor function in essential hypertension. Clin Exp Hypertens (2009) 1.02

Salt inactivates endothelial nitric oxide synthase in endothelial cells. J Nutr (2009) 1.01

Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy. Cardiovasc Res (2006) 1.00

How the kidney is impacted by the perinatal maternal environment to develop hypertension. Biol Reprod (2013) 0.99

Regulation of the epithelial sodium channel (ENaC) by membrane trafficking. Biochim Biophys Acta (2010) 0.99

Signaling mechanisms that link salt retention to hypertension: endogenous ouabain, the Na(+) pump, the Na(+)/Ca(2+) exchanger and TRPC proteins. Biochim Biophys Acta (2010) 0.99

Role of myosin light chain kinase in regulation of basal blood pressure and maintenance of salt-induced hypertension. Am J Physiol Heart Circ Physiol (2011) 0.97

Vascular endothelial ageing, heartbeat after heartbeat. Cardiovasc Res (2009) 0.97

Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension. J Hypertens (2008) 0.97

Dietary salt intake and hypertension. Electrolyte Blood Press (2014) 0.96

The role of ENaC in vascular endothelium. Pflugers Arch (2013) 0.94

Blood pressure and amiloride-sensitive sodium channels in vascular and renal cells. Nat Rev Nephrol (2014) 0.94

Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension. Am J Physiol Heart Circ Physiol (2011) 0.94

Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly? Pflugers Arch (2008) 0.92

Essential hypertension in adolescents and children: Recent advances in causative mechanisms. Indian J Endocrinol Metab (2011) 0.92

Chronic high-NaCl intake prolongs the cardiorenal responses to central N/OFQ and produces regional changes in the endogenous brain NOP receptor system. Am J Physiol Regul Integr Comp Physiol (2008) 0.91

Direct inhibition of basolateral Kir4.1/5.1 and Kir4.1 channels in the cortical collecting duct by dopamine. Am J Physiol Renal Physiol (2013) 0.91

Ouabain-stimulated trafficking regulation of the Na/K-ATPase and NHE3 in renal proximal tubule cells. Mol Cell Biochem (2012) 0.91

Genes involved in vasoconstriction and vasodilation system affect salt-sensitive hypertension. PLoS One (2011) 0.91

Reactive Oxygen Species Modulation of Na/K-ATPase Regulates Fibrosis and Renal Proximal Tubular Sodium Handling. Int J Nephrol (2012) 0.90

Sodium- and phosphorus-based food additives: persistent but surmountable hurdles in the management of nutrition in chronic kidney disease. Adv Chronic Kidney Dis (2013) 0.90

Two barriers for sodium in vascular endothelium? Ann Med (2012) 0.89

Direct activation of ENaC by angiotensin II: recent advances and new insights. Curr Hypertens Rep (2013) 0.89

Activation of the mineralocorticoid receptor increases striatin levels. Am J Hypertens (2011) 0.87

Feedforward activation of endothelial ENaC by high sodium. FASEB J (2014) 0.87

DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure. Cardiovasc Diabetol (2014) 0.86

Long-term High Salt Diet Causes Hypertension and Decreases Renal Expression of Vascular Endothelial Growth Factor in Sprague-Dawley Rats. J Am Soc Hypertens (2010) 0.85

Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension. Gend Med (2012) 0.85

Functional identification of the promoter of SLC4A5, a gene associated with cardiovascular and metabolic phenotypes in the HERITAGE Family Study. Eur J Hum Genet (2009) 0.84

An update on the relationship between the kidney, salt and hypertension. Wien Med Wochenschr (2008) 0.84

The role of salt in the pathogenesis of fructose-induced hypertension. Int J Nephrol (2011) 0.83

Remodeling of atrial ATP-sensitive K⁺ channels in a model of salt-induced elevated blood pressure. Am J Physiol Heart Circ Physiol (2011) 0.83

Central nervous system Gαi2-subunit proteins maintain salt resistance via a renal nerve-dependent sympathoinhibitory pathway. Hypertension (2012) 0.83

Differential effects of dietary sodium intake on blood pressure and atherosclerosis in hypercholesterolemic mice. J Nutr Biochem (2012) 0.83

Association between circulating specific leukocyte types and incident chronic kidney disease: the Atherosclerosis Risk in Communities (ARIC) study. J Am Soc Hypertens (2011) 0.83

Sex differences in salt sensitivity to nitric oxide dependent vasodilation in healthy young adults. J Appl Physiol (1985) (2011) 0.83

Renal denervation prevents stroke and brain injury via attenuation of oxidative stress in hypertensive rats. J Am Heart Assoc (2013) 0.82

Effect of sodium overload on renal function of offspring from diabetic mothers. Pediatr Nephrol (2008) 0.82

NKCC2 is activated in Milan hypertensive rats contributing to the maintenance of salt-sensitive hypertension. Pflugers Arch (2011) 0.81

A multi-component model of the dynamics of salt-induced hypertension in Dahl-S rats. BMC Physiol (2009) 0.81

Essential hypertension: an approach to its etiology and neurogenic pathophysiology. Int J Hypertens (2013) 0.81

Urinary sodium excretion and dietary sources of sodium intake in Chinese postmenopausal women with prehypertension. PLoS One (2014) 0.80

Gene expression responses of threespine stickleback to salinity: implications for salt-sensitive hypertension. Front Genet (2014) 0.80

Primary health care providers' attitudes and counseling behaviors related to dietary sodium reduction. Arch Intern Med (2012) 0.80

Salt controls endothelial and vascular phenotype. Pflugers Arch (2014) 0.80

Effects of dietary sodium on reactive oxygen species formation and endothelial dysfunction in low-density lipoprotein receptor-deficient mice on high-fat diet. Heart Vessels (2008) 0.80

Salt and gene expression: evidence for [Na+]i/[K+]i-mediated signaling pathways. Pflugers Arch (2014) 0.80

A physiological concept unmasking vascular salt sensitivity in man. Pflugers Arch (2012) 0.80

Opioid mechanisms that mediate the palatability of and appetite for salt in sodium replete and deficient states. Physiol Behav (2012) 0.80

Transcriptional and physiological responses to chronic ACTH treatment by the mouse kidney. Physiol Genomics (2009) 0.80

Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study. J Hypertens (2008) 0.80

Chronic antagonism of the mineralocorticoid receptor ameliorates hypertension and end organ damage in a rodent model of salt-sensitive hypertension. Clin Exp Hypertens (2011) 0.79

An emerging concept of vascular salt sensitivity. F1000 Biol Rep (2012) 0.79

Risk factors for high blood pressure in low income children aged 3-4 years. Eur J Pediatr (2013) 0.79

Salt intake in children and its consequences on blood pressure. Pediatr Nephrol (2014) 0.79

Canadian initiatives to prevent hypertension by reducing dietary sodium. Nutrients (2011) 0.79

Solute transport and oxygen consumption along the nephrons: effects of Na+ transport inhibitors. Am J Physiol Renal Physiol (2016) 0.79

Natriuretic hormones in brain function. Front Endocrinol (Lausanne) (2014) 0.79

Renal dopaminergic system: Pathophysiological implications and clinical perspectives. World J Nephrol (2015) 0.79

The association of genetic variations with sensitivity of blood pressure to dietary salt: A narrative literature review. ARYA Atheroscler (2014) 0.79

Evidence for a noradrenergic mechanism causing hypertension and abnormal glucose metabolism in rats with relative deficiency of gamma-melanocyte-stimulating hormone. Exp Physiol (2009) 0.78

Leptin and the Regulation of Renal Sodium Handling and Renal Na-Transporting ATPases: Role in the Pathogenesis of Arterial Hypertension. Curr Cardiol Rev (2010) 0.78

Analysis of correlation between 24-hour urinary sodium and the degree of blood pressure control in patients with chronic kidney disease and non-chronic kidney disease. J Korean Med Sci (2014) 0.78

Perinatal Na+ overload programs raised renal proximal Na+ transport and enalapril-sensitive alterations of Ang II signaling pathways during adulthood. PLoS One (2012) 0.78

High salt-diet reduces SLC14A1 gene expression in the choroid plexus of Dahl salt sensitive rats. Biochem Biophys Res Commun (2015) 0.78

Assessment of dietary intake of children with chronic kidney disease. Pediatr Nephrol (2016) 0.78

Calcium channel blockers, more than diuretics, enhance vascular protective effects of angiotensin receptor blockers in salt-loaded hypertensive rats. PLoS One (2012) 0.77

Hydrogen Sulfide Inhibits High-Salt Diet-Induced Renal Oxidative Stress and Kidney Injury in Dahl Rats. Oxid Med Cell Longev (2015) 0.77

Blood pressure and sodium intake from snacks in adolescents. Eur J Clin Nutr (2015) 0.77

Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet (2006) 5.40

Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet (2011) 4.37

Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab (2005) 4.07

Importance of salt in determining blood pressure in children: meta-analysis of controlled trials. Hypertension (2006) 3.73

Salt intake is related to soft drink consumption in children and adolescents: a link to obesity? Hypertension (2008) 3.68

Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet (2006) 3.65

Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet (2010) 3.36

Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol (2005) 3.20

Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14

SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet (2010) 3.07

How far should salt intake be reduced? Hypertension (2003) 2.86

Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet (2013) 2.83

Reducing population salt intake worldwide: from evidence to implementation. Prog Cardiovasc Dis (2010) 2.64

Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension (2012) 2.31

Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res (2003) 2.29

Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension (2009) 2.29

European consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens (2014) 2.28

The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab (2009) 2.22

Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension (2009) 2.20

Fibromuscular dysplasia. Orphanet J Rare Dis (2007) 2.18

Plasma sodium: ignored and underestimated. Hypertension (2004) 2.15

Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab (2007) 2.06

Change in salt intake affects blood pressure of chimpanzees: implications for human populations. Circulation (2007) 1.99

Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A (2007) 1.98

KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet (2012) 1.93

Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension (2011) 1.89

Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension (2005) 1.89

Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. J Clin Endocrinol Metab (2002) 1.84

Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform. Mol Cell Biol (2003) 1.76

The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS One (2009) 1.75

Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans. Am J Hypertens (2011) 1.72

Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension. Hypertension (2006) 1.72

Functionality of two new polymorphisms in the human renin gene enhancer region. J Hypertens (2002) 1.65

The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients. J Hypertens (2006) 1.63

Modest salt reduction lowers blood pressure in isolated systolic hypertension and combined hypertension. Hypertension (2005) 1.62

Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics. Circulation (2012) 1.61

Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels. Nat Commun (2013) 1.60

Evidence for carotid and radial artery wall subclinical lesions in renal fibromuscular dysplasia. J Hypertens (2003) 1.59

Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol (2011) 1.57

KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension (2011) 1.51

Gene polymorphisms and cytokine plasma levels as predictive factors of complications after cardiopulmonary bypass. J Thorac Cardiovasc Surg (2012) 1.47

Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension. Hypertension (2005) 1.46

Blood pressure loci identified with a gene-centric array. Am J Hum Genet (2011) 1.44

Angiotensin II promotes thoracic aortic dissections and ruptures in Col3a1 haploinsufficient mice. Hypertension (2013) 1.43

Plasma sodium and hypertension. Kidney Int (2004) 1.40

Urinary catecholamines and the relationship with blood pressure and pharmacological therapy. J Hypertens (2016) 1.39

Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum Mol Genet (2011) 1.38

Beneficial effects of potassium on human health. Physiol Plant (2008) 1.23

Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers. Endocrinology (2011) 1.21

Effects of potassium chloride and potassium bicarbonate on endothelial function, cardiovascular risk factors, and bone turnover in mild hypertensives. Hypertension (2010) 1.20

Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension. Proc Natl Acad Sci U S A (2010) 1.18

Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertension (2010) 1.18

Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosus to 16p12.2-p13.13. Circulation (2005) 1.13

Regional left ventricular deformation and geometry analysis provides insights in myocardial remodelling in mild to moderate hypertension. Eur J Echocardiogr (2007) 1.11

Recent advances in the genetics of phaeochromocytoma and functional paraganglioma. Clin Exp Pharmacol Physiol (2008) 1.10

World Salt Awareness Week. J Clin Hypertens (Greenwich) (2011) 1.09

Thyroid function and blood pressure homeostasis in euthyroid subjects. J Clin Endocrinol Metab (2004) 1.09

Dietary salt influences postprandial plasma sodium concentration and systolic blood pressure. Kidney Int (2011) 1.08

Salt: the dying echoes of the food industry. Am J Hypertens (2013) 1.08

Endothelial function and chronic exposure to air pollution in normal male subjects. Hypertension (2007) 1.08

A thyroid nodule revealing a paraganglioma in a patient with a new germline mutation in the succinate dehydrogenase B gene. Eur J Endocrinol (2004) 1.07

Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms. Cardiovasc Res (2010) 1.07

Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiency. Horm Res (2005) 1.06

Genetic determinants of nonmodulating hypertension. Hypertension (2003) 1.06

Familial thoracic aortic aneurysm/dissection with patent ductus arteriosus: genetic arguments for a particular pathophysiological entity. Eur J Hum Genet (2004) 1.05

Estimation of sodium excretion should be made as simple as possible, but not simpler: misleading papers and editorial on spot urines. J Hypertens (2015) 1.04

Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation. Am J Med (2003) 1.04

WNK1-related Familial Hyperkalemic Hypertension results from an increased expression of L-WNK1 specifically in the distal nephron. Proc Natl Acad Sci U S A (2013) 1.03

Cardiovascular expression of the mouse WNK1 gene during development and adulthood revealed by a BAC reporter assay. Am J Pathol (2006) 1.03

Reducing salt intake to prevent hypertension and cardiovascular disease. Rev Panam Salud Publica (2012) 1.02

Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations. J Clin Endocrinol Metab (2012) 1.01

A new methodology for quantification of alternatively spliced exons reveals a highly tissue-specific expression pattern of WNK1 isoforms. PLoS One (2012) 1.00

Amiloride, a specific drug for hypertension in black people with T594M variant? Hypertension (2002) 1.00

Familial hyperkalemic hypertension. J Am Soc Nephrol (2005) 0.99

Variants of the caveolin-1 gene: a translational investigation linking insulin resistance and hypertension. J Clin Endocrinol Metab (2011) 0.98

Urinary free cortisol: an intermediate phenotype and a potential genetic marker for a salt-resistant subset of essential hypertension. J Clin Endocrinol Metab (2007) 0.98

Genotype-phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes. J Hypertens (2010) 0.97

Regulation of WNK1 expression by miR-192 and aldosterone. J Am Soc Nephrol (2010) 0.97

Deletion of WNK1 first intron results in misregulation of both isoforms in renal and extrarenal tissues. Hypertension (2008) 0.96

Salt, blood pressure and the renin-angiotensin system. J Renin Angiotensin Aldosterone Syst (2003) 0.96

WNK1 regulates vasoconstriction and blood pressure response to α 1-adrenergic stimulation in mice. Hypertension (2011) 0.95

Abnormal aldosterone physiology and cardiometabolic risk factors. Hypertension (2013) 0.95

Mutations in KCNJ5 gene cause hyperaldosteronism. Circ Res (2011) 0.95

Incomplete segregation of MYH11 variants with thoracic aortic aneurysms and dissections and patent ductus arteriosus. Eur J Hum Genet (2012) 0.95

Salt, blood pressure and cardiovascular disease. Curr Opin Cardiol (2007) 0.94

Does reducing salt intake increase cardiovascular mortality? Kidney Int (2011) 0.93

Low-renin hypertension, altered sodium homeostasis, and an alpha-adducin polymorphism. Hypertension (2002) 0.93

Angiotensinogen genotype affects renal and adrenal responses to angiotensin II in essential hypertension. Circulation (2002) 0.93

Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives. Hypertension (2005) 0.93

Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses. J Renin Angiotensin Aldosterone Syst (2011) 0.92

Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J Clin Invest (2005) 0.92

Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma. Endocr Pathol (2012) 0.91

Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations. Circ Cardiovasc Genet (2013) 0.90

The functional c.-2G>C variant of the mineralocorticoid receptor modulates blood pressure, renin, and aldosterone levels. Hypertension (2010) 0.90

Dietary sodium: a perspective on recent sodium evidence--its interpretation and controversies. J Clin Hypertens (Greenwich) (2013) 0.89

Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease. J Renin Angiotensin Aldosterone Syst (2006) 0.89

The epithelial sodium channel in hypertension: genetic heterogeneity and implications for treatment with amiloride. Am J Pharmacogenomics (2004) 0.89